[go: up one dir, main page]

FI950587A0 - Metoder användbara vid förebyggande och bahandling av endotoxinförgiftning - Google Patents

Metoder användbara vid förebyggande och bahandling av endotoxinförgiftning

Info

Publication number
FI950587A0
FI950587A0 FI950587A FI950587A FI950587A0 FI 950587 A0 FI950587 A0 FI 950587A0 FI 950587 A FI950587 A FI 950587A FI 950587 A FI950587 A FI 950587A FI 950587 A0 FI950587 A0 FI 950587A0
Authority
FI
Finland
Prior art keywords
prevention
treatment
methods useful
endotoxin poisoning
endotoxin
Prior art date
Application number
FI950587A
Other languages
English (en)
Finnish (fi)
Other versions
FI950587L (sv
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of FI950587A0 publication Critical patent/FI950587A0/sv
Publication of FI950587L publication Critical patent/FI950587L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI950587A 1992-08-12 1995-02-10 Metoder användbara vid förebyggande och bahandling av endotoxinförgiftning FI950587L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/928,930 US5344822A (en) 1992-08-12 1992-08-12 Methods useful in endotoxin prophylaxis and therapy
PCT/US1993/007453 WO1994004177A1 (en) 1992-08-12 1993-08-09 Methods useful in endotoxin prophylaxis and therapy

Publications (2)

Publication Number Publication Date
FI950587A0 true FI950587A0 (sv) 1995-02-10
FI950587L FI950587L (sv) 1995-04-06

Family

ID=25457027

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950587A FI950587L (sv) 1992-08-12 1995-02-10 Metoder användbara vid förebyggande och bahandling av endotoxinförgiftning

Country Status (7)

Country Link
US (3) US5344822A (sv)
EP (1) EP0658116A4 (sv)
JP (1) JPH08500117A (sv)
AU (1) AU671853B2 (sv)
CA (1) CA2142295A1 (sv)
FI (1) FI950587L (sv)
WO (1) WO1994004177A1 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
US5771081A (en) * 1994-02-28 1998-06-23 Korea Telecommunication Authority Bit system for transmitting digital video data
US20010043924A1 (en) * 1994-04-05 2001-11-22 Exponential Biotherapies, Inc. Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system
JPH09511397A (ja) * 1994-04-05 1997-11-18 エクスポネンシャル バイオセラピーズ，インコーポレイテッド 遺伝子型改変バクテリオファージによる抗菌治療
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
DE19516247A1 (de) * 1995-05-03 1996-11-07 Albrecht Prof Dr Wendel Pyrogen-Untersuchungsverfahren
IL123509A (en) * 1995-08-31 2007-05-15 Yissum Res Dev Co Therapeutic lipoprotein composition containing lipid vesicles which bind apoproteins and uses therof
AU764747B2 (en) * 1995-09-06 2003-08-28 Kyowa Hakko Kogyo Co. Ltd. Lipid metabolism improving agent
WO1997009059A1 (fr) * 1995-09-06 1997-03-13 Kyowa Hakko Kogyo Co., Ltd. Agent lipidique d'amelioration du metabolisme
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
AU2001278336B2 (en) * 2000-07-31 2007-01-18 Ottawa Heart Institute Research Corporation Charged phospholipid compositions and methods for their use
US7166578B2 (en) * 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7144862B2 (en) * 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
WO2004068969A1 (en) * 2003-02-05 2004-08-19 N.V. Nutricia Enteral composition for the prevention and/or treatment of sepsis
GB0329254D0 (en) 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
TR201802446T4 (tr) * 2004-05-19 2018-03-21 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Sodyum deoksikolat içeren enjeksiyonluk bileşim.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
RU2448977C2 (ru) * 2004-09-16 2012-04-27 Зе Риджентс Оф Зи Юнивесити Оф Кэлифонье Обладающий способностью облегчать по меньшей мере один симптом воспалительного состояния пептид, содержащая его фармацевтическая композиция и способ лечения атеросклероза с их помощью
NZ555826A (en) 2004-12-06 2009-11-27 Univ California Methods for improving the structure and function of arterioles
EP2269623A1 (en) * 2005-04-29 2011-01-05 The Regents of The University of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US20080293639A1 (en) * 2005-04-29 2008-11-27 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
KR101413361B1 (ko) * 2005-08-29 2014-06-27 셉시큐어,엘.엘.씨. 그람-양성 박테리아에 의해 유발되는 질병의 치료 또는예방 방법
US7355777B2 (en) * 2006-05-09 2008-04-08 Texas Instruments Incorporated Energy storage structures using electromechanically active materials for micro electromechanical systems
US20080206142A1 (en) * 2006-06-16 2008-08-28 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
US20080227686A1 (en) * 2006-06-16 2008-09-18 Lipid Sciences, Inc. Novel Peptides that Promote Lipid Efflux
EP2041174A2 (en) * 2006-06-16 2009-04-01 Lipid Sciences, Inc. Novel peptides that promote lipid efflux
WO2008039843A2 (en) * 2006-09-26 2008-04-03 Lipid Sciences, Inc. Novel peptides that promote lipid efflux
CA2704729C (en) 2007-08-28 2020-06-23 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
JP2010537638A (ja) 2007-08-28 2010-12-09 ユーエービー リサーチ ファウンデーション 合成アポリポ蛋白質ｅ模倣ポリペプチドおよび使用方法
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
BR112017001860A2 (pt) 2014-07-31 2018-02-27 Uab Research Foundation peptídeo sintético, composição farmacêutica, métodos, regime de dosagem, e, anticorpo monoclonal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131460A1 (de) * 1981-08-08 1983-02-24 B. Braun Melsungen Ag, 3508 Melsungen Fettemsulsion fuer parenterale ernaehrung
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
JPH07507554A (ja) * 1992-06-12 1995-08-24 エヌ・ブイ・イノゲネテイクス・エス・エイ 新規ペプチドおよびタンパク質，それらの調製方法，ならびにコレステロール受容体としてのそれらの使用
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy

Also Published As

Publication number Publication date
AU671853B2 (en) 1996-09-12
EP0658116A1 (en) 1995-06-21
FI950587L (sv) 1995-04-06
AU4805193A (en) 1994-03-15
WO1994004177A1 (en) 1994-03-03
US5614507A (en) 1997-03-25
US5344822A (en) 1994-09-06
JPH08500117A (ja) 1996-01-09
CA2142295A1 (en) 1994-03-03
EP0658116A4 (en) 1997-10-01
US5506218A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
FI950587L (sv) Metoder användbara vid förebyggande och bahandling av endotoxinförgiftning
FI945625L (sv) Indolkarbazol-imider och deras användning
FI944310A0 (sv) Heteroarylamino- och heteroarylsulfonamidosubstituerade 3-bensylaminometylpiperidiner och motsvarande föreningar
FI953351L (sv) Blandningar och deras användning
FI944549A0 (sv) Föreningar nyttiga för behandling av allergiska och inflammatoriska sjukdomer
DE69331967D1 (de) Gefässstent und zugehörige einführungsvorrichtung
BR9304732A (pt) Estrutura absorvente e artigo absorvente
DE69117410D1 (de) System zur Erkennung und Beendung von durch einen Herzschrittmacher induzierten Tachykardien
FI940640L (sv) Organoaluminoxyprodukter samt användning
FI953838L (sv) Imidazopyridiner och användning av dem vid behandling av gastrointestinala sjukdomar
DE69424640D1 (de) Filmbehandlungsmethode und System
NO180408C (no) Brannlukkeanordning
FI944624A0 (sv) 4-arylaminobensopyran- och liknande föreningar
FI935728L (sv) Substituerade 4-fenylpyridoner och 4-fenyl-2-alkoxipyridiner
NO971900D0 (no) Blandinger og behandling av multippel sklerose
FI955426L (sv) Ytbehandlingsprodukter och förfaranden för deras framställning
FI933201L (fi) Vaerme- och kylvals
FI951060L (sv) Formulationer och behandlingsmetoder
FI960585L (sv) Användning av oligosackarider för hindrande och behandling av vävnadsåldrande
FI964227L (sv) Heparin bindande protein för behandling av sepsis och förfaranden för dess framställning
DE69309572D1 (de) Auftragsverfahren und -vorrichtung
DE59306085D1 (de) Haar- und körperbehandlungsmittel
FI933019L (fi) Bensotiazepin- och bensoxatzepinderivat
FI944687L (sv) Sammansättning för profylax och behandling av närsynthet
FI943213L (sv) Process för framställning av 3-acylestrariener och acylbenzener

Legal Events

Date Code Title Description
FD Application lapsed